Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
EBITDA as a percentage of revenue
3Y CAGR
+31.6%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
2.3x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | 12.61% | +221.5% |
| 2024 | -10.38% | -22.7% |
| 2023 | -8.46% | -252.9% |
| 2022 | 5.53% | +101.4% |
| 2021 | -400.27% | - |
| 2020 | 0.00% | - |
| 2019 | 0.00% | - |